Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.130
+0.220 (24.18%)
At close: May 13, 2026, 4:00 PM EDT
1.110
-0.020 (-1.77%)
Pre-market: May 14, 2026, 5:48 AM EDT

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
251185657294218747
Market Cap Growth
10.78%-71.77%123.02%35.18%-70.83%1711.45%
Enterprise Value
265.82197.3689.56268.88113.69570.43
Last Close Price
1.130.965.052.842.117.25
PE Ratio
--3.69-4.01-2.65-17.58-10.98
PS Ratio
124.4590.96--139.18591.27
PB Ratio
19.2359.63-12.4721.741.866.11
P/TBV Ratio
16.9748.86-11.3621.681.862.37
P/FCF Ratio
--1.75-6.59-3.90-3.02-9.17
P/OCF Ratio
--1.76-6.69-4.02-3.06-9.20
EV/Sales Ratio
131.8596.81--72.65451.64
EV/EBITDA Ratio
--1.96-6.43-2.91-1.49-7.82
EV/EBIT Ratio
--1.82-6.03-2.69-1.34-7.02
EV/FCF Ratio
--1.86-6.92-3.56-1.58-7.01
Debt / Equity Ratio
5.4620.08-1.484.050.410.40
Debt / EBITDA Ratio
-0.62-0.64-0.75-0.62-0.77-0.70
Debt / FCF Ratio
-0.64-0.61-0.81-0.76-0.81-0.63
Net Debt / Equity Ratio
1.494.62-0.68-1.70-0.80-1.43
Net Debt / EBITDA Ratio
-0.16-0.14-0.330.251.222.39
Net Debt / FCF Ratio
-0.17-0.13-0.360.301.292.14
Asset Turnover
0.020.02000.010.01
Inventory Turnover
0.991.43----
Quick Ratio
3.032.772.254.367.7620.42
Current Ratio
3.933.692.404.527.8820.75
Return on Equity (ROE)
-1022.52%164.78%760.17%-169.81%-8.70%22.10%
Return on Assets (ROA)
-100.38%-85.07%-85.98%-60.17%-34.46%-41.30%
Return on Invested Capital (ROIC)
-231.99%-170.37%-209.97%-264.45%-176.39%-144.92%
Return on Capital Employed (ROCE)
-118.41%-100.17%-100.48%-67.94%-36.76%-43.79%
Earnings Yield
-38.90%-27.07%-24.95%-37.68%-5.69%-9.10%
FCF Yield
--57.14%-15.18%-25.67%-33.14%-10.90%
Buyback Yield / Dilution
-40.56%-33.49%-14.56%-0.36%-157.82%0.00%
Total Shareholder Return
-40.56%-33.49%-14.56%-0.36%-157.82%0.00%
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q